Frontiers in Genetics (Aug 2022)
Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
- Sibin Zhang,
- Xu Xiao,
- Yu Wang,
- Tianjun Song,
- Chenlong Li,
- Hongbo Bao,
- Qing Liu,
- Guiyin Sun,
- Xiaoyang Sun,
- Tianqi Su,
- Tianjiao Fu,
- Yujie Wang,
- Peng Liang
Affiliations
- Sibin Zhang
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Xu Xiao
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Yu Wang
- Department of Esophageal Surgery, Harbin Medical University Cancer Hospital, Harbin, China
- Tianjun Song
- Department of Medicine II, University Hospital LMU Munich, Munich, Germany
- Chenlong Li
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Hongbo Bao
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Qing Liu
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Guiyin Sun
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Xiaoyang Sun
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Tianqi Su
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Tianjiao Fu
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Yujie Wang
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- Peng Liang
- Department of Neurosurgery, Harbin Medical University Cancer Hospital, Harbin, China
- DOI
- https://doi.org/10.3389/fgene.2022.961153
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
